Skip to search formSkip to main contentSkip to account menu

Johnson and Johnson

Known as: Johnson & Johnson 
health product manufacturer
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
IntroductionTheoretical risks of biologic agents remain under study.ObjectiveThe aim of this study was to integrate 1-year safety… 
Review
2014
Review
2014
External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
Venous thromboembolic (VTE) risk assessment remains an important issue in hospitalised, acutely-ill medical patients, and several… 
2014
2014
STARR with CONTOUR® TRANSTAR™ device for obstructed defecation syndrome: one-year real-world outcomes of the European TRANSTAR registry
PurposeStapled transanal rectal resection (STARR) in patients with obstructive defecation syndrome (ODS) is limited by the… 
2013
2013
First novel anti-tuberculosis drug in 40 years
  • R. Osborne
  • Nature Biotechnology
  • 2013
  • Corpus ID: 20639439
89 opment organization, established in 2000 to boost research into TB drugs. Sirturo, unlike other antibiotics that attack the… 
Highly Cited
2012
Highly Cited
2012
Sting of Alzheimer's failures offset by upcoming prevention trials
  • Asher Mullard
  • Nature reviews. Drug discovery
  • 2012
  • Corpus ID: 1980413
Three prevention trials in asymptomatic Alzheimer's disease patients will attempt to validate the amyloid hypothesis, evaluate… 
Review
2010
Review
2010
How Informatics Can Potentiate Precompetitive Open‐Source Collaboration to Jump‐Start Drug Discovery and Development
Much enthusiasm and energy are being directed toward open‐source software approaches, precompetitive data sharing, and external… 
Highly Cited
2009
Highly Cited
2009
Numerical and Clinical Accuracy of a Continuous Glucose Monitoring System during Intravenous Insulin Therapy in the Surgical and Burn Intensive Care Units
Background: Intensive insulin therapy (IIT) for glycemic control in critically ill patients has been shown to be beneficial… 
Highly Cited
2008
Highly Cited
2008
The Bacteria Fight Back
In their ongoing war against antibiotics, the bacteria seem to be winning, and the drug pipeline is verging on empty. 
2008
2008
Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
BackgroundIn clinical practice, physicians often need to change the antipsychotic medications they give to patients because of an… 
2005
2005
An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening.
In this paper we describe an initial reproducibility study of 12 proprietary compounds followed by the assessment of 51 marketed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)